Completed PHASE4 INTERVENTIONAL 2-arm NCT00176124

Leukocyte Depletion of Autologous Whole Blood (LDAWB-2001)

Leukocyte Depletion of Autologous Whole Blood: Impact on Perioperative Infection Rate and Length of Hospital Stay for Hip Arthroplasty Patients

Sponsor: Heidelberg University

Conditions Bacterial Infection Infection Sepsis

Interventions Leukocyte filtration/Depletion leukocyte depletion of whole blood

Updated 7 times since 2017 Last updated: Jun 9, 2008 Started: Apr 30, 2001 Primary completion: Apr 30, 2005 Completion: Sep 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bacterial Infection and Infection and is currently completed. Heidelberg University leads this study, which shows 7 recorded versions since 2001 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Dec 2024 — Sep 2025 [monthly]

Completed PHASE4
Sep 2024 — Dec 2024 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heidelberg University
Philipps University Marburg

Data source: Heidelberg University

For direct contact, visit the study record on ClinicalTrials.gov .

Leukocyte Depletion of Autologous Whole Blood (LDAWB-2001)

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials